{"id":"W3167509426","doi":"10.1200/jco.2021.39.15_suppl.4502","title":"Health-related quality-of-life (HRQoL) analysis from the phase 3 CLEAR trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) or everolimus (EVE) versus sunitinib (SUN) for patients (pts) with advanced renal cell carcinoma (aRCC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Everolimus; Internal medicine; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005950271,0.0009862756,0.001683556,0.0004363483,0.0002889503,0.000795703,0.0007872765,0.0008126991,0.005894935],"category_scores_gemma":[0.002982189,0.0003926784,0.003225124,0.0007412459,0.0005467612,0.0006539417,0.0007088907,0.002512133,0.0005970616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006406671,"about_ca_system_score_gemma":0.0009895905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007207529,"about_ca_topic_score_gemma":0.00177715,"domain_scores_codex":[0.9971582,0.002001867,0.0001711393,0.0002016979,0.0002951671,0.0001719689],"domain_scores_gemma":[0.9975271,0.00073021,0.0008886096,0.0001721591,0.0001669565,0.0005149695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9451691,0.006707537,0.01438078,0.001522424,0.007852445,0.00006378911,0.00007633523,0.002003312,0.004175978,0.0001042131,0.002961618,0.01498247],"study_design_scores_gemma":[0.6280115,0.2126015,0.1396523,0.0001868885,0.01000753,0.0003534075,0.00009904231,0.002156979,0.002690705,0.0003345038,0.00384857,0.00005711002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9775435,0.004837352,0.0006138509,0.0004622194,0.00008346234,0.002304767,0.01173202,0.00002934205,0.002393513],"genre_scores_gemma":[0.9817882,0.001259042,0.0009955133,0.000457092,0.0001011954,0.002525377,0.01201453,0.00001838553,0.0008406776],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005950271,"threshold_uncertainty_score":0.03146845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2048934587289442,"score_gpt":0.465467439747845,"score_spread":0.2605739810189008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}